Yinghe Yimai has successfully concluded its Series A funding round, raising over 100 million yuan, led by Far Vision Capital. The company is deeply committed to the research and development of medical imaging AI technology and has triumphantly introduced the "Yinghe Miya®" medical imaging base model. This model transcends the constraints of single-disease focus, pioneering research and development centered on examination items. The fresh influx of funds will empower Yinghe Yimai to expedite the refinement of its base model, propel industrial expansion, and bolster team development. Yinghe Yimai's core offerings encompass a smart imaging system, a data asset platform, a scientific research innovation platform, and an AI tool deployment platform, all aimed at constructing an open and collaborative intelligent ecosystem. Currently, the company has forged partnerships with numerous prestigious hospitals and institutions to jointly advance the practical application of medical imaging services.